Literature DB >> 1934165

Synthesis and antitumor activity of 20(S)-camptothecin derivatives: carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin.

S Sawada1, S Okajima, R Aiyama, K Nokata, T Furuta, T Yokokura, E Sugino, K Yamaguchi, T Miyasaka.   

Abstract

Novel 36 derivatives (6), bonding the phenolic hydroxyl group of 7-ethyl-10-hydroxycamptothecin (4) with diamines through a monocarbamate linkage, were synthesized and their antitumor activity was evaluated in vivo. The derivatives were soluble in water as their HCl salts with the E lactone ring intact and exhibited significant antitumor activity. One of the derivatives, 6-27 showed excellent activity against L1210 leukemia and other murine tumors. The structure of its hydrochloride trihydrate (CPT-11) was determined by spectroscopic and crystallographic methods.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1934165     DOI: 10.1248/cpb.39.1446

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  23 in total

1.  MM3(96) parameterization for camptothecin analogs: an ab initio and molecular mechanics study.

Authors:  S W Carrigan; J H Lii; J P Bowen
Journal:  J Comput Aided Mol Des       Date:  1997-01       Impact factor: 3.686

2.  Quantification of irinotecan, SN38, and SN38G in human and porcine plasma by ultra high-performance liquid chromatography-tandem mass spectrometry and its application to hepatic chemoembolization.

Authors:  Xiaohong Chen; Cody J Peer; Raul Alfaro; Tian Tian; Shawn D Spencer; William D Figg
Journal:  J Pharm Biomed Anal       Date:  2012-01-16       Impact factor: 3.935

Review 3.  Strategies for the Optimization of Natural Leads to Anticancer Drugs or Drug Candidates.

Authors:  Zhiyan Xiao; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2015-09-11       Impact factor: 12.944

Review 4.  Anticancer drug discovery and pharmaceutical chemistry: a history.

Authors:  Miguel F Braña; Ana Sánchez-Migallón
Journal:  Clin Transl Oncol       Date:  2006-10       Impact factor: 3.405

Review 5.  Natural products as leads to anticancer drugs.

Authors:  M Gordaliza
Journal:  Clin Transl Oncol       Date:  2007-12       Impact factor: 3.405

6.  A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma.

Authors:  Peter C Enzinger; Matthew H Kulke; Jeffrey W Clark; David P Ryan; Haesook Kim; Craig C Earle; Michele M Vincitore; Ann L Michelini; Robert J Mayer; Charles S Fuchs
Journal:  Dig Dis Sci       Date:  2005-12       Impact factor: 3.199

7.  A self-contained enzyme activating prodrug cytotherapy for preclinical melanoma.

Authors:  Gwi-Moon Seo; Raja Shekar Rachakatla; Sivasai Balivada; Marla Pyle; Tej B Shrestha; Matthew T Basel; Carl Myers; Hongwang Wang; Masaaki Tamura; Stefan H Bossmann; Deryl L Troyer
Journal:  Mol Biol Rep       Date:  2011-05-13       Impact factor: 2.316

8.  Spatial organization of topoisomerase I-mediated DNA cleavage induced by camptothecin-oligonucleotide conjugates.

Authors:  Paola B Arimondo; Stéphane Angenault; Ludovic Halby; Alexandre Boutorine; Frédéric Schmidt; Claude Monneret; Thérèse Garestier; Jian-Sheng Sun; Christian Bailly; Claude Hélène
Journal:  Nucleic Acids Res       Date:  2003-07-15       Impact factor: 16.971

9.  CEACAM5-targeted therapy of human colonic and pancreatic cancer xenografts with potent labetuzumab-SN-38 immunoconjugates.

Authors:  Serengulam V Govindan; Thomas M Cardillo; Sung-Ju Moon; Hans J Hansen; David M Goldenberg
Journal:  Clin Cancer Res       Date:  2009-09-29       Impact factor: 12.531

Review 10.  Camptothecins: a review of their chemotherapeutic potential.

Authors:  Hulya Ulukan; Peter W Swaan
Journal:  Drugs       Date:  2002       Impact factor: 9.546

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.